APO Research

APO RESEARCH · REPORT

Microbial Cell Bank Generation Service

Selected research

Market Analysis & Forecast

Global Microbial Cell Bank Generation Service Market Analysis and Forecast 2026-2032

Market perspective

The global Microbial Cell Bank Generation Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Microbial Cell Bank Generation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Microbial Cell Bank Generation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Microbial Cell Bank Generation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Microbial Cell Bank Generation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Microbial Cell Bank Generation Service include Altogen Labs, Esco Aster, 53Biologics, Eurofins, Microbiosci, Takara Bio, WuXi Biologics, VALIDOGEN and Leinco Technologies, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Microbial Cell Bank Generation Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Microbial Cell Bank Generation Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Microbial Cell Bank Generation Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Microbial Cell Bank Generation Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Microbial Cell Bank Generation Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Microbial Cell Bank Generation Service revenue, projected growth trends, production technology, application and end-user industry.

Microbial Cell Bank Generation Service Segment by Company

Altogen Labs

Esco Aster

53Biologics

Eurofins

Microbiosci

Takara Bio

WuXi Biologics

VALIDOGEN

Leinco Technologies

Pharmaron

Lonza

Mycenax

Clongen Laboratories

ProteoGenix

Creative Biogene

Charles River

BioReliance

Microbial Cell Bank Generation Service Segment by Type

Research Cell Banks (RCB)

Master Cell Banks (MCB)

Working Cell Banks (WCB)

End-of-production Cell Banks (EOPC)

Microbial Cell Bank Generation Service Segment by Application

Biological Research

Pharmaceutics

Others

Microbial Cell Bank Generation Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microbial Cell Bank Generation Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Microbial Cell Bank Generation Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microbial Cell Bank Generation Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Microbial Cell Bank Generation Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Microbial Cell Bank Generation Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Microbial Cell Bank Generation Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Microbial Cell Bank Generation Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Research Cell Banks (RCB) Major Player Table 3. Master Cell Banks (MCB) Major Player Table 4. Working Cell Banks (WCB) Major Player Table 5. End-of-production Cell Banks (EOPC) Major Player Table 6. Global Microbial Cell Bank Generation Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Biological Research Major Player Table 8. Pharmaceutics Major Player Table 9. Others Major Player Table 10. Microbial Cell Bank Generation Service Industry Trends Table 11. Microbial Cell Bank Generation Service Industry Drivers Table 12. Microbial Cell Bank Generation Service Industry Opportunities and Challenges Table 13. Microbial Cell Bank Generation Service Industry Restraints Table 14. Global Microbial Cell Bank Generation Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Microbial Cell Bank Generation Service Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Microbial Cell Bank Generation Service Market Share by Region (2021-2026) Table 17. Global Microbial Cell Bank Generation Service Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Microbial Cell Bank Generation Service Market Share by Region (2027-2032) Table 19. Global Microbial Cell Bank Generation Service Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Microbial Cell Bank Generation Service Revenue Market Share by Players (2021-2026) Table 21. Global Microbial Cell Bank Generation Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Microbial Cell Bank Generation Service Key Players Headquarters & Area Served Table 23. Global Microbial Cell Bank Generation Service Players, Product Type & Application Table 24. Global Microbial Cell Bank Generation Service Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Microbial Cell Bank Generation Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Microbial Cell Bank Generation Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Microbial Cell Bank Generation Service Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Microbial Cell Bank Generation Service Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Microbial Cell Bank Generation Service Revenue Market Share by Type (2021-2026) Table 31. Global Microbial Cell Bank Generation Service Revenue Market Share by Type (2027-2032) Table 32. Global Microbial Cell Bank Generation Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Microbial Cell Bank Generation Service Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Microbial Cell Bank Generation Service Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Microbial Cell Bank Generation Service Revenue Market Share by Application (2021-2026) Table 36. Global Microbial Cell Bank Generation Service Revenue Market Share by Application (2027-2032) Table 37. Altogen Labs Company Information Table 38. Altogen Labs Business Overview Table 39. Altogen Labs Microbial Cell Bank Generation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Altogen Labs Microbial Cell Bank Generation Service Product Portfolio Table 41. Altogen Labs Recent Development Table 42. Esco Aster Company Information Table 43. Esco Aster Business Overview Table 44. Esco Aster Microbial Cell Bank Generation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Esco Aster Microbial Cell Bank Generation Service Product Portfolio Table 46. Esco Aster Recent Development Table 47. 53Biologics Company Information Table 48. 53Biologics Business Overview Table 49. 53Biologics Microbial Cell Bank Generation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. 53Biologics Microbial Cell Bank Generation Service Product Portfolio Table 51. 53Biologics Recent Development Table 52. Eurofins Company Information Table 53. Eurofins Business Overview Table 54. Eurofins Microbial Cell Bank Generation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Eurofins Microbial Cell Bank Generation Service Product Portfolio Table 56. Eurofins Recent Development Table 57. Microbiosci Company Information Table 58. Microbiosci Business Overview Table 59. Microbiosci Microbial Cell Bank Generation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Microbiosci Microbial Cell Bank Generation Service Product Portfolio Table 61. Microbiosci Recent Development Table 62. Takara Bio Company Information Table 63. Takara Bio Business Overview Table 64. Takara Bio Microbial Cell Bank Generation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Takara Bio Microbial Cell Bank Generation Service Product Portfolio Table 66. Takara Bio Recent Development Table 67. WuXi Biologics Company Information Table 68. WuXi Biologics Business Overview Table 69. WuXi Biologics Microbial Cell Bank Generation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. WuXi Biologics Microbial Cell Bank Generation Service Product Portfolio Table 71. WuXi Biologics Recent Development Table 72. VALIDOGEN Company Information Table 73. VALIDOGEN Business Overview Table 74. VALIDOGEN Microbial Cell Bank Generation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. VALIDOGEN Microbial Cell Bank Generation Service Product Portfolio Table 76. VALIDOGEN Recent Development Table 77. Leinco Technologies Company Information Table 78. Leinco Technologies Business Overview Table 79. Leinco Technologies Microbial Cell Bank Generation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Leinco Technologies Microbial Cell Bank Generation Service Product Portfolio Table 81. Leinco Technologies Recent Development Table 82. Pharmaron Company Information Table 83. Pharmaron Business Overview Table 84. Pharmaron Microbial Cell Bank Generation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Pharmaron Microbial Cell Bank Generation Service Product Portfolio Table 86. Pharmaron Recent Development Table 87. Lonza Company Information Table 88. Lonza Business Overview Table 89. Lonza Microbial Cell Bank Generation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Lonza Microbial Cell Bank Generation Service Product Portfolio Table 91. Lonza Recent Development Table 92. Mycenax Company Information Table 93. Mycenax Business Overview Table 94. Mycenax Microbial Cell Bank Generation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Mycenax Microbial Cell Bank Generation Service Product Portfolio Table 96. Mycenax Recent Development Table 97. Clongen Laboratories Company Information Table 98. Clongen Laboratories Business Overview Table 99. Clongen Laboratories Microbial Cell Bank Generation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Clongen Laboratories Microbial Cell Bank Generation Service Product Portfolio Table 101. Clongen Laboratories Recent Development Table 102. ProteoGenix Company Information Table 103. ProteoGenix Business Overview Table 104. ProteoGenix Microbial Cell Bank Generation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. ProteoGenix Microbial Cell Bank Generation Service Product Portfolio Table 106. ProteoGenix Recent Development Table 107. Creative Biogene Company Information Table 108. Creative Biogene Business Overview Table 109. Creative Biogene Microbial Cell Bank Generation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Creative Biogene Microbial Cell Bank Generation Service Product Portfolio Table 111. Creative Biogene Recent Development Table 112. Charles River Company Information Table 113. Charles River Business Overview Table 114. Charles River Microbial Cell Bank Generation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Charles River Microbial Cell Bank Generation Service Product Portfolio Table 116. Charles River Recent Development Table 117. BioReliance Company Information Table 118. BioReliance Business Overview Table 119. BioReliance Microbial Cell Bank Generation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. BioReliance Microbial Cell Bank Generation Service Product Portfolio Table 121. BioReliance Recent Development Table 122. North America Microbial Cell Bank Generation Service Revenue by Type (2021-2026) & (US$ Million) Table 123. North America Microbial Cell Bank Generation Service Revenue by Type (2027-2032) & (US$ Million) Table 124. North America Microbial Cell Bank Generation Service Revenue by Application (2021-2026) & (US$ Million) Table 125. North America Microbial Cell Bank Generation Service Revenue by Application (2027-2032) & (US$ Million) Table 126. North America Microbial Cell Bank Generation Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. North America Microbial Cell Bank Generation Service Revenue by Country (2021-2026) & (US$ Million) Table 128. North America Microbial Cell Bank Generation Service Revenue by Country (US$ Million) & (2027-2032) Table 129. Europe Microbial Cell Bank Generation Service Revenue by Type (2021-2026) & (US$ Million) Table 130. Europe Microbial Cell Bank Generation Service Revenue by Type (2027-2032) & (US$ Million) Table 131. Europe Microbial Cell Bank Generation Service Revenue by Application (2021-2026) & (US$ Million) Table 132. Europe Microbial Cell Bank Generation Service Revenue by Application (2027-2032) & (US$ Million) Table 133. Europe Microbial Cell Bank Generation Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Europe Microbial Cell Bank Generation Service Revenue by Country (2021-2026) & (US$ Million) Table 135. Europe Microbial Cell Bank Generation Service Revenue by Country (US$ Million) & (2027-2032) Table 136. China Microbial Cell Bank Generation Service Revenue by Type (2021-2026) & (US$ Million) Table 137. China Microbial Cell Bank Generation Service Revenue by Type (2027-2032) & (US$ Million) Table 138. China Microbial Cell Bank Generation Service Revenue by Application (2021-2026) & (US$ Million) Table 139. China Microbial Cell Bank Generation Service Revenue by Application (2027-2032) & (US$ Million) Table 140. Asia Microbial Cell Bank Generation Service Revenue by Type (2021-2026) & (US$ Million) Table 141. Asia Microbial Cell Bank Generation Service Revenue by Type (2027-2032) & (US$ Million) Table 142. Asia Microbial Cell Bank Generation Service Revenue by Application (2021-2026) & (US$ Million) Table 143. Asia Microbial Cell Bank Generation Service Revenue by Application (2027-2032) & (US$ Million) Table 144. Asia Microbial Cell Bank Generation Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 145. Asia Microbial Cell Bank Generation Service Revenue by Region (US$ Million) & (2021-2026) Table 146. Asia Microbial Cell Bank Generation Service Revenue by Region (US$ Million) & (2027-2032) Table 147. SAMEA Microbial Cell Bank Generation Service Revenue by Type (2021-2026) & (US$ Million) Table 148. SAMEA Microbial Cell Bank Generation Service Revenue by Type (2027-2032) & (US$ Million) Table 149. SAMEA Microbial Cell Bank Generation Service Revenue by Application (2021-2026) & (US$ Million) Table 150. SAMEA Microbial Cell Bank Generation Service Revenue by Application (2027-2032) & (US$ Million) Table 151. SAMEA Microbial Cell Bank Generation Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. SAMEA Microbial Cell Bank Generation Service Revenue by Country (2021-2026) & (US$ Million) Table 153. SAMEA Microbial Cell Bank Generation Service Revenue by Country (US$ Million) & (2027-2032) Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. Microbial Cell Bank Generation Service Image Figure 2. Global Microbial Cell Bank Generation Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Microbial Cell Bank Generation Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Research Cell Banks (RCB) Image Figure 5. Master Cell Banks (MCB) Image Figure 6. Working Cell Banks (WCB) Image Figure 7. End-of-production Cell Banks (EOPC) Image Figure 8. Global Microbial Cell Bank Generation Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Microbial Cell Bank Generation Service Market Size Share 2021 VS 2025 VS 2032 Figure 10. Biological Research Image Figure 11. Pharmaceutics Image Figure 12. Others Image Figure 13. Global Microbial Cell Bank Generation Service Market Size (US$ Million) & (2021-2032) Figure 14. Global Microbial Cell Bank Generation Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Microbial Cell Bank Generation Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Microbial Cell Bank Generation Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Microbial Cell Bank Generation Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Microbial Cell Bank Generation Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Microbial Cell Bank Generation Service Revenue Market Share by Type (2021-2032) Figure 21. Global Microbial Cell Bank Generation Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Microbial Cell Bank Generation Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Microbial Cell Bank Generation Service Revenue Market Share by Application (2021-2032) Figure 24. North America Microbial Cell Bank Generation Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Microbial Cell Bank Generation Service Revenue Share by Type (2021-2032) Figure 26. North America Microbial Cell Bank Generation Service Revenue Share by Application (2021-2032) Figure 27. North America Microbial Cell Bank Generation Service Revenue Share by Country (2021-2032) Figure 28. United States Microbial Cell Bank Generation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Microbial Cell Bank Generation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Microbial Cell Bank Generation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Microbial Cell Bank Generation Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Microbial Cell Bank Generation Service Revenue Share by Type (2021-2032) Figure 33. Europe Microbial Cell Bank Generation Service Revenue Share by Application (2021-2032) Figure 34. Europe Microbial Cell Bank Generation Service Revenue Share by Country (2021-2032) Figure 35. Germany Microbial Cell Bank Generation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Microbial Cell Bank Generation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Microbial Cell Bank Generation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Microbial Cell Bank Generation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Microbial Cell Bank Generation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Microbial Cell Bank Generation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Microbial Cell Bank Generation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Microbial Cell Bank Generation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Microbial Cell Bank Generation Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Microbial Cell Bank Generation Service Revenue Share by Type (2021-2032) Figure 45. China Microbial Cell Bank Generation Service Revenue Share by Application (2021-2032) Figure 46. Asia Microbial Cell Bank Generation Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Microbial Cell Bank Generation Service Revenue Share by Type (2021-2032) Figure 48. Asia Microbial Cell Bank Generation Service Revenue Share by Application (2021-2032) Figure 49. Asia Microbial Cell Bank Generation Service Revenue Share by Region (2021-2032) Figure 50. Japan Microbial Cell Bank Generation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Microbial Cell Bank Generation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Microbial Cell Bank Generation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Microbial Cell Bank Generation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Microbial Cell Bank Generation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Microbial Cell Bank Generation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Microbial Cell Bank Generation Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Microbial Cell Bank Generation Service Revenue Share by Type (2021-2032) Figure 58. SAMEA Microbial Cell Bank Generation Service Revenue Share by Application (2021-2032) Figure 59. SAMEA Microbial Cell Bank Generation Service Revenue Share by Country (2021-2032) Figure 60. Brazil Microbial Cell Bank Generation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Microbial Cell Bank Generation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Microbial Cell Bank Generation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Microbial Cell Bank Generation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Microbial Cell Bank Generation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Microbial Cell Bank Generation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Microbial Cell Bank Generation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Microbial Cell Bank Generation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Microbial Cell Bank Generation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Microbial Cell Bank Generation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Microbial Cell Bank Generation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Research Cell Banks (RCB)
  • Master Cell Banks (MCB)
  • Working Cell Banks (WCB)
  • End-of-production Cell Banks (EOPC)
Applications
  • Biological Research
  • Pharmaceutics
  • Others
Companies covered
  • Altogen Labs
  • Esco Aster
  • 53Biologics
  • Eurofins
  • Microbiosci
  • Takara Bio
  • WuXi Biologics
  • VALIDOGEN
  • Leinco Technologies
  • Pharmaron
  • Lonza
  • Mycenax
  • Clongen Laboratories
  • ProteoGenix
  • Creative Biogene
  • Charles River
  • BioReliance

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Microbial Cell Bank Generation Service Market by Type
  3. 1.2.1 Global Microbial Cell Bank Generation Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Research Cell Banks (RCB)
  5. 1.2.3 Master Cell Banks (MCB)
  6. 1.2.4 Working Cell Banks (WCB)
  7. 1.2.5 End-of-production Cell Banks (EOPC)
  8. 1.3 Microbial Cell Bank Generation Service Market by Application
  9. 1.3.1 Global Microbial Cell Bank Generation Service Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Biological Research
  11. 1.3.3 Pharmaceutics
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Microbial Cell Bank Generation Service Market Dynamics
  1. 2.1 Microbial Cell Bank Generation Service Industry Trends
  2. 2.2 Microbial Cell Bank Generation Service Industry Drivers
  3. 2.3 Microbial Cell Bank Generation Service Industry Opportunities and Challenges
  4. 2.4 Microbial Cell Bank Generation Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Microbial Cell Bank Generation Service Market Perspective (2021-2032)
  2. 3.2 Global Microbial Cell Bank Generation Service Growth Trends by Region
  3. 3.2.1 Global Microbial Cell Bank Generation Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Microbial Cell Bank Generation Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Microbial Cell Bank Generation Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Microbial Cell Bank Generation Service Revenue by Players
  2. 4.1.1 Global Microbial Cell Bank Generation Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Microbial Cell Bank Generation Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Microbial Cell Bank Generation Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Microbial Cell Bank Generation Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Microbial Cell Bank Generation Service Key Players Headquarters & Area Served
  7. 4.4 Global Microbial Cell Bank Generation Service Players, Product Type & Application
  8. 4.5 Global Microbial Cell Bank Generation Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Microbial Cell Bank Generation Service Market CR5 and HHI
  11. 4.6.3 2025 Microbial Cell Bank Generation Service Tier 1, Tier 2, and Tier 3
5 Microbial Cell Bank Generation Service Market Size by Type
  1. 5.1 Global Microbial Cell Bank Generation Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Microbial Cell Bank Generation Service Revenue by Type (2021-2032)
  3. 5.3 Global Microbial Cell Bank Generation Service Revenue Market Share by Type (2021-2032)
6 Microbial Cell Bank Generation Service Market Size by Application
  1. 6.1 Global Microbial Cell Bank Generation Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Microbial Cell Bank Generation Service Revenue by Application (2021-2032)
  3. 6.3 Global Microbial Cell Bank Generation Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Altogen Labs
  2. 7.1.1 Altogen Labs Company Information
  3. 7.1.2 Altogen Labs Business Overview
  4. 7.1.3 Altogen Labs Microbial Cell Bank Generation Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Altogen Labs Microbial Cell Bank Generation Service Product Portfolio
  6. 7.1.5 Altogen Labs Recent Developments
  7. 7.2 Esco Aster
  8. 7.2.1 Esco Aster Company Information
  9. 7.2.2 Esco Aster Business Overview
  10. 7.2.3 Esco Aster Microbial Cell Bank Generation Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Esco Aster Microbial Cell Bank Generation Service Product Portfolio
  12. 7.2.5 Esco Aster Recent Developments
  13. 7.3 53Biologics
  14. 7.3.1 53Biologics Company Information
  15. 7.3.2 53Biologics Business Overview
  16. 7.3.3 53Biologics Microbial Cell Bank Generation Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 53Biologics Microbial Cell Bank Generation Service Product Portfolio
  18. 7.3.5 53Biologics Recent Developments
  19. 7.4 Eurofins
  20. 7.4.1 Eurofins Company Information
  21. 7.4.2 Eurofins Business Overview
  22. 7.4.3 Eurofins Microbial Cell Bank Generation Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Eurofins Microbial Cell Bank Generation Service Product Portfolio
  24. 7.4.5 Eurofins Recent Developments
  25. 7.5 Microbiosci
  26. 7.5.1 Microbiosci Company Information
  27. 7.5.2 Microbiosci Business Overview
  28. 7.5.3 Microbiosci Microbial Cell Bank Generation Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Microbiosci Microbial Cell Bank Generation Service Product Portfolio
  30. 7.5.5 Microbiosci Recent Developments
  31. 7.6 Takara Bio
  32. 7.6.1 Takara Bio Company Information
  33. 7.6.2 Takara Bio Business Overview
  34. 7.6.3 Takara Bio Microbial Cell Bank Generation Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Takara Bio Microbial Cell Bank Generation Service Product Portfolio
  36. 7.6.5 Takara Bio Recent Developments
  37. 7.7 WuXi Biologics
  38. 7.7.1 WuXi Biologics Company Information
  39. 7.7.2 WuXi Biologics Business Overview
  40. 7.7.3 WuXi Biologics Microbial Cell Bank Generation Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 WuXi Biologics Microbial Cell Bank Generation Service Product Portfolio
  42. 7.7.5 WuXi Biologics Recent Developments
  43. 7.8 VALIDOGEN
  44. 7.8.1 VALIDOGEN Company Information
  45. 7.8.2 VALIDOGEN Business Overview
  46. 7.8.3 VALIDOGEN Microbial Cell Bank Generation Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 VALIDOGEN Microbial Cell Bank Generation Service Product Portfolio
  48. 7.8.5 VALIDOGEN Recent Developments
  49. 7.9 Leinco Technologies
  50. 7.9.1 Leinco Technologies Company Information
  51. 7.9.2 Leinco Technologies Business Overview
  52. 7.9.3 Leinco Technologies Microbial Cell Bank Generation Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Leinco Technologies Microbial Cell Bank Generation Service Product Portfolio
  54. 7.9.5 Leinco Technologies Recent Developments
  55. 7.10 Pharmaron
  56. 7.10.1 Pharmaron Company Information
  57. 7.10.2 Pharmaron Business Overview
  58. 7.10.3 Pharmaron Microbial Cell Bank Generation Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Pharmaron Microbial Cell Bank Generation Service Product Portfolio
  60. 7.10.5 Pharmaron Recent Developments
  61. 7.11 Lonza
  62. 7.11.1 Lonza Company Information
  63. 7.11.2 Lonza Business Overview
  64. 7.11.3 Lonza Microbial Cell Bank Generation Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Lonza Microbial Cell Bank Generation Service Product Portfolio
  66. 7.11.5 Lonza Recent Developments
  67. 7.12 Mycenax
  68. 7.12.1 Mycenax Company Information
  69. 7.12.2 Mycenax Business Overview
  70. 7.12.3 Mycenax Microbial Cell Bank Generation Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Mycenax Microbial Cell Bank Generation Service Product Portfolio
  72. 7.12.5 Mycenax Recent Developments
  73. 7.13 Clongen Laboratories
  74. 7.13.1 Clongen Laboratories Company Information
  75. 7.13.2 Clongen Laboratories Business Overview
  76. 7.13.3 Clongen Laboratories Microbial Cell Bank Generation Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Clongen Laboratories Microbial Cell Bank Generation Service Product Portfolio
  78. 7.13.5 Clongen Laboratories Recent Developments
  79. 7.14 ProteoGenix
  80. 7.14.1 ProteoGenix Company Information
  81. 7.14.2 ProteoGenix Business Overview
  82. 7.14.3 ProteoGenix Microbial Cell Bank Generation Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 ProteoGenix Microbial Cell Bank Generation Service Product Portfolio
  84. 7.14.5 ProteoGenix Recent Developments
  85. 7.15 Creative Biogene
  86. 7.15.1 Creative Biogene Company Information
  87. 7.15.2 Creative Biogene Business Overview
  88. 7.15.3 Creative Biogene Microbial Cell Bank Generation Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Creative Biogene Microbial Cell Bank Generation Service Product Portfolio
  90. 7.15.5 Creative Biogene Recent Developments
  91. 7.16 Charles River
  92. 7.16.1 Charles River Company Information
  93. 7.16.2 Charles River Business Overview
  94. 7.16.3 Charles River Microbial Cell Bank Generation Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Charles River Microbial Cell Bank Generation Service Product Portfolio
  96. 7.16.5 Charles River Recent Developments
  97. 7.17 BioReliance
  98. 7.17.1 BioReliance Company Information
  99. 7.17.2 BioReliance Business Overview
  100. 7.17.3 BioReliance Microbial Cell Bank Generation Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 BioReliance Microbial Cell Bank Generation Service Product Portfolio
  102. 7.17.5 BioReliance Recent Developments
8 North America
  1. 8.1 North America Microbial Cell Bank Generation Service Revenue (2021-2032)
  2. 8.2 North America Microbial Cell Bank Generation Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Microbial Cell Bank Generation Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Microbial Cell Bank Generation Service Revenue by Type (2027-2032)
  5. 8.3 North America Microbial Cell Bank Generation Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Microbial Cell Bank Generation Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Microbial Cell Bank Generation Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Microbial Cell Bank Generation Service Revenue by Application (2027-2032)
  9. 8.5 North America Microbial Cell Bank Generation Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Microbial Cell Bank Generation Service Revenue by Country
  11. 8.6.1 North America Microbial Cell Bank Generation Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Microbial Cell Bank Generation Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Microbial Cell Bank Generation Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Microbial Cell Bank Generation Service Revenue (2021-2032)
  2. 9.2 Europe Microbial Cell Bank Generation Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Microbial Cell Bank Generation Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Microbial Cell Bank Generation Service Revenue by Type (2027-2032)
  5. 9.3 Europe Microbial Cell Bank Generation Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Microbial Cell Bank Generation Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Microbial Cell Bank Generation Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Microbial Cell Bank Generation Service Revenue by Application (2027-2032)
  9. 9.5 Europe Microbial Cell Bank Generation Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Microbial Cell Bank Generation Service Revenue by Country
  11. 9.6.1 Europe Microbial Cell Bank Generation Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Microbial Cell Bank Generation Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Microbial Cell Bank Generation Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Microbial Cell Bank Generation Service Revenue (2021-2032)
  2. 10.2 China Microbial Cell Bank Generation Service Revenue by Type (2021-2032)
  3. 10.2.1 China Microbial Cell Bank Generation Service Revenue by Type (2021-2026)
  4. 10.2.2 China Microbial Cell Bank Generation Service Revenue by Type (2027-2032)
  5. 10.3 China Microbial Cell Bank Generation Service Revenue Share by Type (2021-2032)
  6. 10.4 China Microbial Cell Bank Generation Service Revenue by Application (2021-2032)
  7. 10.4.1 China Microbial Cell Bank Generation Service Revenue by Application (2021-2026)
  8. 10.4.2 China Microbial Cell Bank Generation Service Revenue by Application (2027-2032)
  9. 10.5 China Microbial Cell Bank Generation Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Microbial Cell Bank Generation Service Revenue (2021-2032)
  2. 11.2 Asia Microbial Cell Bank Generation Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Microbial Cell Bank Generation Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Microbial Cell Bank Generation Service Revenue by Type (2027-2032)
  5. 11.3 Asia Microbial Cell Bank Generation Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Microbial Cell Bank Generation Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Microbial Cell Bank Generation Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Microbial Cell Bank Generation Service Revenue by Application (2027-2032)
  9. 11.5 Asia Microbial Cell Bank Generation Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Microbial Cell Bank Generation Service Revenue by Country
  11. 11.6.1 Asia Microbial Cell Bank Generation Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Microbial Cell Bank Generation Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Microbial Cell Bank Generation Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Microbial Cell Bank Generation Service Revenue (2021-2032)
  2. 12.2 SAMEA Microbial Cell Bank Generation Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Microbial Cell Bank Generation Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Microbial Cell Bank Generation Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Microbial Cell Bank Generation Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Microbial Cell Bank Generation Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Microbial Cell Bank Generation Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Microbial Cell Bank Generation Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Microbial Cell Bank Generation Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Microbial Cell Bank Generation Service Revenue by Country
  11. 12.6.1 SAMEA Microbial Cell Bank Generation Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Microbial Cell Bank Generation Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Microbial Cell Bank Generation Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research